Study of Alzheimer's Disease Progression in Mice
Author Information
Author(s): Mastrangelo Michael A, Bowers William J
Primary Institution: University of Rochester Medical Center
Hypothesis
The study aims to document the temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice.
Conclusion
The study provides a detailed assessment of the progression of Alzheimer's disease-related pathologies in 3xTg-AD mice over a 26-month period.
Supporting Evidence
- Intracellular amyloid-beta accumulation is detectable as early as 2 months of age.
- Phospho-tau appears at 6 months, indicating early tau pathology.
- Microglial activation progressively increases with age, especially in the hippocampus.
- Extracellular amyloid-beta deposition begins at 15 months, with significant plaque burden by 26 months.
Takeaway
Researchers looked at how Alzheimer's disease changes in mice over time, finding that certain brain problems get worse as the mice age.
Methodology
The study used immunohistochemistry to assess various AD-related pathologies in the brains of male 3xTg-AD mice at different ages.
Potential Biases
Potential bias due to the exclusive use of male mice and the specific genetic background of the 3xTg-AD model.
Limitations
The study only examined male mice, which may limit the generalizability of the findings to females.
Participant Demographics
Male triple-transgenic mice aged 2 to 26 months.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website